Emerging Biopharma
Flexible solutions. Responsive teams. Data-driven insights.
Explore IQVIA by region
As a global community, IQVIA continuously invests and commits to advancing human health.
Europe
Asia & Oceania
Middle East & Africa
EMEA Thought Leadership
Life Sciences Solutions
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn More
Commercial Solutions
Commercial Solutions (desc)
Contract Sales and Medical Solutions
Contract Sales and Medical Solutions (desc)
Financial Services
Financial Services (desc)
Information Solutions
Information Solutions (desc)
Medical Affairs
Medical Affairs (desc)
Real World Evidence
Real World Evidence (desc)
Healthcare Solutions
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn More
Medical Device and Diagnostic Solutions
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn More
U.S. Government Solutions
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn More
The IQVIA difference
Explore IQVIA by region
As a global community, IQVIA continuously invests and commits to advancing human health.
Americas
Europe
Asia & Oceania
Middle East & Africa
EMEA Thought Leadership
Article
Prevailing Trends in Emerging Biopharma
Strong innovation, greater independence, increasing promotional pressure
Aug 24, 2022
- Locations
- United States
- Prevailing Trends in Emerging Biopharma
Get instant access
IQVIA presented the first in a series of virtual learning sessions for emerging biopharmaceutical (EBP) companies on the critical success factors for product commercialization. This article summarizes the first session, which focused on prevailing trends in levels of innovation, go-to-market strategies, and promotional spending.
Related solutions
Industry Segments
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.